Analysis of chemotherapy selection for locally advanced squamous cell carcinoma of head and neck (SCCHN) in a commercially insured population in the United States

MLA

Christine G. Gourin, et al. “Analysis of Chemotherapy Selection for Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) in a Commercially Insured Population in the United States.” Journal of Clinical Oncology, vol. 34, May 2016, p. 6066. EBSCOhost, https://doi.org/10.1200/jco.2016.34.15_suppl.6066.

APA

Christine G. Gourin, Ana P. Kiess, Hyunseok Kang, & Arlene A. Forastiere. (2016). Analysis of chemotherapy selection for locally advanced squamous cell carcinoma of head and neck (SCCHN) in a commercially insured population in the United States. Journal of Clinical Oncology, 34, 6066. https://doi.org/10.1200/jco.2016.34.15_suppl.6066

Chicago

Christine G. Gourin, Ana P. Kiess, Hyunseok Kang, and Arlene A. Forastiere. 2016. “Analysis of Chemotherapy Selection for Locally Advanced Squamous Cell Carcinoma of Head and Neck (SCCHN) in a Commercially Insured Population in the United States.” Journal of Clinical Oncology 34 (May): 6066. doi:10.1200/jco.2016.34.15_suppl.6066.